Crown Laboratories Acquires Revance Therapeutics
Crown Laboratories acquired Revance Therapeutics for $924.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Crown Laboratories
- Acquired Company
- Revance Therapeutics
- Price
- $924.0M
- Acquisition Type
- Merger
- Announced
- August 12, 2024
Canonical: https://fsome.com/acquisitions/crown-laboratories-acquires-revance-therapeutics-8052962 · For the full deal terms, timeline, and press references, please enable JavaScript.